跳至主要内容
临床试验/NCT00364494
NCT00364494终止不适用

Effect of Moderate Hemodilution During Cardiopulmonary Bypass on Postoperative Outcome Following Cardiac Surgery

Università Vita-Salute San Raffaele2 个研究点 分布在 1 个国家开始时间: 2006年11月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
试验地点
2
主要终点
renal function

研究概览

简要总结

An hematocrit of 21-25% is supposed to perform the best organ protection during cardiopulmonary bypass for cardiac surgery.

The investigators want to establish the best timing for a transfusion (in patients with a predicted low hematocrit during cardiopulmonary bypass) and the efficacy of preprocedural hemodilution (in patients with a predicted high hematocrit during cardiopulmonary bypass) in patients undergoing cardiac surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Undergoing cardiac surgery

排除标准

  • Age < 18 years old
  • Not signing written consent
  • Age < 65 years old (subgroup 1)
  • Emergency, aortic stenosis, main left coronary stenosis (subgroup 2)

结局指标

主要结局

renal function

次要结局

  • exitus
  • sepsis
  • other organ damage
  • prolonged mechanical ventilation, Intensive Care Unit (ICU) and hospital stay

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验